Tanner Health and Healthliant Ventures partner with Optellum to launch an artificial intelligence (AI) platform designed to detect lung cancer.
As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...
Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...
Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...
At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to ...
Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...
OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results